<SEC-DOCUMENT>0001193125-26-232717-index.html : 20260520
<SEC-HEADER>0001193125-26-232717.hdr.sgml : 20260520
<ACCEPTANCE-DATETIME>20260520163515
ACCESSION NUMBER:		0001193125-26-232717
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		11
CONFORMED PERIOD OF REPORT:	20260520
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20260520
DATE AS OF CHANGE:		20260520

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PALVELLA THERAPEUTICS, INC.
		CENTRAL INDEX KEY:			0001583648
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				300784346
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37471
		FILM NUMBER:		261004568

	BUSINESS ADDRESS:	
		STREET 1:		353 W. LANCASTER AVENUE
		STREET 2:		SUITE 200
		CITY:			WAYNE
		STATE:			PA
		ZIP:			19087
		BUSINESS PHONE:		(484) 253-1461

	MAIL ADDRESS:	
		STREET 1:		353 W. LANCASTER AVENUE
		STREET 2:		SUITE 200
		CITY:			WAYNE
		STATE:			PA
		ZIP:			19087

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Pieris Pharmaceuticals, Inc.
		DATE OF NAME CHANGE:	20241213

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PIERIS PHARMACEUTICALS, INC.
		DATE OF NAME CHANGE:	20141218

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Marika Inc.
		DATE OF NAME CHANGE:	20130805
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>pvla-20260520.htm
<DESCRIPTION>8-K
<TEXT>
Document 1 - file: pvla-20260520.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>pvla-ex99_1.htm
<DESCRIPTION>PRESS RELEASE ISSUED BY PALVELLA THERAPEUTICS, INC. ON MAY 20, 2026
<TEXT>
Document 2 - file: pvla-ex99_1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>img6060170_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 3 - file: img6060170_0.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>pvla-20260520.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
<TEXT>
Document 4 - file: pvla-20260520.xsd

</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 6 - file: R1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 7 - file: report.css

</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 8 - file: Show.js

</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 10 - file: FilingSummary.html

Document 10 - RAW XML: FilingSummary.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>12
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 12 - file: MetaLinks.json

</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>13
<FILENAME>0001193125-26-232717-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 13 - file: 0001193125-26-232717-xbrl.zip

</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>pvla-20260520_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 14 - file: pvla-20260520_htm.html

Document 14 - RAW XML: pvla-20260520_htm.xml

</DOCUMENT>
</SEC-DOCUMENT>